Novo Nordisk Agrees To Cap Insulin Costs At $35 In Minn. Settlement Agreement

( January 29, 2025, 3:10 PM EST) -- NEWARK, N.J. — Novo Nordisk Inc. and Minnesota reached an agreement in which the drug maker agreed to make its insulin XE "insulin"  products available to consumers in Minnesota for no more than $35 for a monthly subscription, according to a settlement agreement filed in a New Jersey federal court....